tiprankstipranks
Tryptamine Therapeutics Limited (AU:ENP)
ASX:ENP
Australian Market
ENP
Tryptamine Therapeutics
RESEARCH TOOLSreports
Want to see AU:ENP full AI Analyst Report?

Tryptamine Therapeutics (ENP) Financial Statements

15 Followers

Tryptamine Therapeutics Financial Overview

Tryptamine Therapeutics's market cap is currently AU$62.01M. The company's EPS TTM is AU$; its P/E ratio is -9.56; Tryptamine Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Aug 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueAU$ 0.00AU$ 0.00AU$ 618.57KAU$ 99.73KAU$ 0.00
Gross ProfitAU$ -54.34KAU$ -6.77KAU$ 618.57KAU$ 99.73KAU$ -1.01M
Operating IncomeAU$ -6.73MAU$ -4.97MAU$ -9.59MAU$ -14.11MAU$ -12.67M
EBITDAAU$ -5.27MAU$ -6.70MAU$ -5.10MAU$ -8.27MAU$ -11.66M
Net IncomeAU$ -5.33MAU$ -6.14MAU$ -7.13MAU$ -10.08MAU$ -8.47M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 3.03MAU$ 5.37MAU$ 1.64MAU$ 4.85MAU$ 12.72M
Total AssetsAU$ 6.66MAU$ 7.45MAU$ 5.88MAU$ 13.61MAU$ 21.46M
Total DebtAU$ 0.00AU$ 0.00AU$ 1.53MAU$ 3.74MAU$ 1.36M
Net DebtAU$ -3.03MAU$ -5.37MAU$ -109.30KAU$ -1.10MAU$ -11.37M
Total LiabilitiesAU$ 699.17KAU$ 1.83MAU$ 1.75MAU$ 4.81MAU$ 2.59M
Stockholders' EquityAU$ 5.96MAU$ 5.62MAU$ 4.13MAU$ 8.81MAU$ 18.87M
Cash Flow
Free Cash FlowAU$ -7.90MAU$ -6.00MAU$ -4.03MAU$ -9.72MAU$ -9.51M
Operating Cash FlowAU$ -7.77MAU$ -6.00MAU$ -4.03MAU$ -8.59MAU$ -7.89M
Investing Cash FlowAU$ -133.40KAU$ 1.68MAU$ -9.08KAU$ -1.24MAU$ -1.80M
Financing Cash FlowAU$ 5.60MAU$ 9.27MAU$ 2.39MAU$ 1.95MAU$ 20.61M
Currency in AUD

Tryptamine Therapeutics Earnings and Revenue History

Income Statement >

Tryptamine Therapeutics Debt to Assets

Balance Sheet >

Tryptamine Therapeutics Cash Flow

Cash Flow >

Tryptamine Therapeutics Forecast EPS vs Actual EPS

Earnings >